Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Ex-Hamas Wife Whose Father Helped Create the Terrorist Group Meets Jesus in a Miraculous Dream

Gym in Los Angeles Revokes Membership of Woman Who Opposed Man in Women's Locker Room

American Consumers Footing the Bill: Supreme Court Hears Arguments on Trump's Tariff Power

These Two Officials Would Make an Unstoppable Presidential Ticket, Trump Says

High Stakes on the High Seas as US, China Test Limits of Military Power

FAA Slashes Flights at 40 Airports as Democrat Shutdown Grounds America

NYC's First Muslim, Socialist Mayor the Top Story as Democrats Sweep the Off-Term Elections

Dems Win in VA with First Female Governor, Jones Overcomes Murder Text Scandal to Win AG

Texas Voters Approve Requiring Judges to Deny Bail for Certain Violent Felony Charges

Hamas Returns Remains of Last American Hostage; US Proposes 'Stabilization Force' for Post-War Gaza

Parent Groups Demand 50-State Audit to Eliminate DEI in Schools [WATCH]

UPS Plane Crashes and Explodes at a Kentucky Airport, Leaving at Least 9 Dead and Others Missing

Former VP Dick Cheney Dead at 84

Make-or-Break Decision Coming: President Trump's Tariffs on Trial

'Revival on Halloween Night': Hundreds Worship Jesus as Baptisms Unfold in Streets of Baton Rouge

Canadian MP: Reciting 'Hateful' Bible Verses About Homosexuality In Public Should Be Illegal

Canada's Supreme Court Rules 1-Year Minimum Jail Sentence for Child Porn Possession 'Unconstitutional'

The New York Times Exposed a Trafficking Crisis. But Refuses to Name the Men Responsible

Google Caught Hiding Elon Musk's New Grokipedia, Instead Promotes Leftist Wikipedia

How Trump Killed a UN 'Global Green Tax' that Would Have 'Devastated' at the 11th Hour: Breitbart Exclusive